Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Jennifer Chuy"'
Autor:
Ana Acuna-Villaorduna MD, Viswanathan Shankar Dr.P.H, Michael Wysota MD, Amanda Jirgal BA, Rafi Kabarriti MD, Sarah Bellemare MD, Inessa Goldman MD, Andreas Kaubisch MD, Santiago Aparo MD, Sanjay Goel MD, MS, Jennifer Chuy MD
Publikováno v:
Cancer Control, Vol 29 (2022)
Introduction Perioperative therapy is standard for patients with borderline-resectable pancreatic ductal adenocarcinoma (BR-PDAC); however, an optimal neoadjuvant regimen is lacking. We assessed the efficacy of FOLFIRINOX chemotherapy followed by gem
Externí odkaz:
https://doaj.org/article/5ec1ac5d0669454798a73d5d02b36860
Autor:
Justin Y. Tang, Nitin Ohri, Rafi Kabarriti, Santiago Aparo, Jennifer Chuy, Sanjay Goel, Jonathan M. Schwartz, Milan Kinkhabwala, Andreas Kaubisch, Chandan Guha
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 2018 (2018)
Background & Aims. The significance of short-term changes in model for end-stage liver disease and Sodium (MELD-Na) following hepatocellular carcinoma (HCC) diagnosis is unknown. In this report, we explore the value of the rate of short-term changes
Externí odkaz:
https://doaj.org/article/6a0bbc6cdde4478aab2d34798f68fe46
Autor:
Vicente Ramos‐Santillan, Patricia Friedmann, Mariam Eskander, Jennifer Chuy, Michael Parides, Haejin In
Publikováno v:
Journal of Surgical Oncology. 127:56-65
Multimodality treatment improves survival for gastric cancer (GC). However, the effect of treatment sequence by stage remains unclear. We aim to compare outcomes between patients receiving neoadjuvant(neoadj) and adjuvant chemotherapy (adj).Nonmetast
Autor:
Patrick C Lee, Edik M Blais, Jun Gong, Arsen Osipov, Natalie Moshayedi, Shant Thomassian, Camille Ng, Jennifer Chuy, Lynn M Matrisian, III Emanuel F Petricoin, Michael J Pishvaian, Andrew E Hendifar
Publikováno v:
Endocrine Abstracts.
Autor:
null Ana Acuna-Villaorduna, null Viswanathan Shankar, null Michael Wysota, null Amanda Jirgal, null Rafi Kabarriti, null Sarah Bellemare, null Inessa Goldman, null Andreas Kaubisch, null Santiago Aparo, null Sanjay Goel, null Jennifer Chuy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b5848e16639811e8b81e2ce112c09f4a
https://doi.org/10.1177/10732748221134411/v2/response1
https://doi.org/10.1177/10732748221134411/v2/response1
Autor:
Angelica D’Aiello, Numa Rahman, N. Patrik Brodin, Manish Dave, Sakshi Jasra, Andreas Kaubisch, Rafi Kabarriti, Jennifer Chuy
Publikováno v:
Journal of Gastrointestinal Cancer.
As life expectancy for HIV patients improve, hepatocellular carcinoma (HCC) has become a non-AIDS defining illness with a high impact on morbidity and mortality of HIV-infected individuals. We sought to compare outcomes in HIV- versus non-HIV-infecte
Autor:
Benson Chellakkan Selvanesan, Dinesh Chandra, Wilber Quispe-Tintaya, Arthee Jahangir, Ankur Patel, Kiran Meena, Rodrigo Alberto Alves Da Silva, Madeline Friedman, Lisa Gabor, Olivia Khouri, Steven K. Libutti, Ziqiang Yuan, Jenny Li, Sarah Siddiqui, Amanda Beck, Lydia Tesfa, Wade Koba, Jennifer Chuy, John C. McAuliffe, Rojin Jafari, David Entenberg, Yarong Wang, John Condeelis, Vera DesMarais, Vinod Balachandran, Xusheng Zhang, Ken Lin, Claudia Gravekamp
Publikováno v:
Sci Transl Med
Pancreatic ductal adenocarcinoma (PDAC) is a highly metastatic disease. Tumors are poorly immunogenic and immunosuppressive, preventing T cell activation in the tumor microenvironment. Here, we present a microbial-based immunotherapeutic treatment fo
Publikováno v:
Gastroenterology. 158:S-1553
Publikováno v:
Precision Cancer Medicine. 3:9-9
Carcinoma of unknown primary (CUP) is estimated to be 2% of diagnosed cancers. In the era of precision medicine, we are able to use more tools to identify a possible source of primary, direct potential treatments as well as provide prognostic informa
Autor:
Devika Rao, Atrayee Basu Mallick, Titto Augustine, Cecilia Daroqui, Jeeshan Jiffry, Amartej Merla, Imran Chaudhary, Raviraja Seetharaman, Arjun Sood, Srikanth Gajavelli, Santiago Aparo, Lakshmi Rajdev, Andreas Kaubisch, Jennifer Chuy, Radhashree Maitra, Sanjay Goel
Publikováno v:
Cancer Research. 79:4932-4932
Background: Oxaliplatin confers tumoricidal effect by forming platinum-DNA adducts and is an integral part of the treatment paradigm for patients with colorectal cancer (CRC). The nucleotide excision repair pathway (NERP) plays a crucial role in tiss